Drug Price Trends for NDC 69452-0316

Average Pharmacy Cost for 69452-0316

Drug Name	NDC	Price/Unit ($)	Unit	Date
CEVIMELINE HCL 30 MG CAPSULE	69452-0316-20	0.70384	EACH	2025-04-23
CEVIMELINE HCL 30 MG CAPSULE	69452-0316-20	0.74509	EACH	2025-03-19
CEVIMELINE HCL 30 MG CAPSULE	69452-0316-20	0.70791	EACH	2025-02-19

Best Wholesale Price for NDC 69452-0316

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 69452-0316

In the ever-evolving pharmaceutical landscape, understanding market dynamics and projecting future trends for specific drugs is crucial for industry professionals. This article delves into the market analysis and price projections for the drug identified by the National Drug Code (NDC) 69452-0316, offering valuable insights for stakeholders in the pharmaceutical sector.

Understanding NDC 69452-0316

The National Drug Code (NDC) is a unique identifier for human drugs in the United States. NDC 69452-0316 represents a specific drug product, with each segment of the code providing important information:

• Labeler Code: 69452 (identifies the manufacturer or distributor)
• Product Code: 031 (specifies the strength, dosage form, and formulation)
• Package Code: 6 (indicates the package size and type)

While the search results don't provide specific information about the drug associated with NDC 69452-0316, we can analyze market trends and pricing mechanisms that apply to similar products in the pharmaceutical industry.

The Orphan Drug Market: A Broader Context

To understand the market dynamics that might affect NDC 69452-0316, it's helpful to look at broader trends in the pharmaceutical industry, particularly in the orphan drug market.

Over the last decade, orphan drugs have consistently outpaced their non-orphan counterparts in growth. They've doubled their market share in global prescription drug sales, climbing from less than 10% in 2014 to nearly 20% today.[1]

This significant growth in the orphan drug market demonstrates the increasing focus on rare diseases and specialized treatments. However, recent trends suggest a potential shift in this landscape.

Slowing Growth in the Orphan Drug Market

While the orphan drug market has experienced substantial growth, there are signs that this rapid expansion may be slowing:

• The growth advantage for orphan drugs is starting to narrow
• Orphan drug sales increased by nearly 11% annually up to 2023
• This rate is expected to just scrape double digits through the rest of this decade

Despite this slowdown, the market for niche products remains strong, with projections indicating continued growth, albeit at a more modest pace.

Pricing Mechanisms and Market Forces

Understanding the pricing mechanisms and market forces at play is crucial for projecting future prices for NDC 69452-0316 and similar drugs.

Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)

For drugs under the Medicaid Drug Rebate Program, two key factors influence pricing:

1. Average Manufacturer Price (AMP): The average price paid by wholesalers for the drug
2. Unit Rebate Amount (URA): The rebate amount per unit of the drug

The ceiling price for these drugs is calculated as AMP minus URA, adjusted for package and case pack sizes[2].

Maximum Allowable Cost (MAC) Lists

Pharmacy benefit managers use Maximum Allowable Cost (MAC) lists to determine reimbursement rates for drugs. These lists must be updated regularly to ensure fair reimbursement and competitive pricing[5].

The 340B Drug Pricing Program

If NDC 69452-0316 is part of the 340B Drug Pricing Program, it would be subject to specific pricing regulations. This program requires drug manufacturers to offer discounted prices on certain outpatient drugs to eligible hospitals and other covered entities.

Market Trends Affecting Drug Pricing

Several market trends can influence the pricing and demand for drugs like NDC 69452-0316:

1. Legislative changes
2. Shifts in care delivery from inpatient to outpatient settings
3. Rising drug prices
4. Competitive landscape, including the presence of generic or branded competitors

Impact of the Inflation Reduction Act

The Inflation Reduction Act and other potential regulatory shifts could significantly impact the pharmaceutical landscape, including pricing strategies for drugs like NDC 69452-0316.

Projecting Future Prices

To project future prices for NDC 69452-0316, a comprehensive analysis of historical pricing data is essential. This includes reviewing:

• Ceiling price charts
• AMP trends
• URA fluctuations

By identifying patterns and considering market forces, it's possible to make informed projections about future pricing trends.

Example Calculation

While we don't have specific data for NDC 69452-0316, we can illustrate a hypothetical pricing calculation:

If the AMP for a drug is $100 per unit and the URA is $20 per unit, the ceiling price would be $80 per unit. For a package of 10 units with a case pack size of 5 packages, the adjusted ceiling price would be $80 10 5 = $4000 per case pack[2].

The Role of NDCs in Market Analysis

National Drug Codes play a crucial role in market analysis and price projections. They provide a standardized system for identifying drugs, which is essential for:

1. Tracking sales and market share
2. Analyzing pricing trends
3. Ensuring regulatory compliance
4. Facilitating reimbursement processes

NDC Directory and Its Limitations

The FDA maintains an NDC Directory, which contains information about finished drug products, unfinished drugs, and compounded drug products. However, it's important to note that:

• Inclusion in the NDC Directory does not indicate FDA approval
• The directory may not include all listed drugs
• Information in the directory is the responsibility of the labeler submitting the data[5]

These factors must be considered when using NDC data for market analysis and price projections.

Factors Influencing Market Demand

Several factors can influence the market demand for a drug like NDC 69452-0316:

1. Therapeutic efficacy
2. Side effect profile
3. Ease of administration
4. Cost-effectiveness compared to alternative treatments
5. Inclusion in treatment guidelines
6. Reimbursement policies of insurance providers

Understanding these factors is crucial for accurate market analysis and price projections.

Competitive Landscape Analysis

To project future prices and market performance for NDC 69452-0316, it's essential to analyze the competitive landscape:

1. Identify direct competitors (drugs with similar therapeutic effects)
2. Analyze pricing strategies of competitors
3. Assess the potential for new market entrants, including generic versions
4. Consider the impact of emerging therapies or treatment modalities

This analysis helps in understanding potential pricing pressures and market opportunities.

Global Market Considerations

While NDCs are specific to the United States, global market trends can still impact pricing and demand for drugs like NDC 69452-0316:

1. International pricing benchmarks
2. Global supply chain dynamics
3. Regulatory changes in major pharmaceutical markets
4. Currency fluctuations

These global factors can indirectly influence pricing strategies and market performance in the U.S.

Technological Advancements and Their Impact

Technological advancements in drug development, manufacturing, and administration can significantly impact market dynamics and pricing:

1. Improved manufacturing processes leading to cost reductions
2. Novel drug delivery systems enhancing efficacy or patient convenience
3. Personalized medicine approaches potentially segmenting the market

These advancements should be considered when projecting future market trends and pricing for NDC 69452-0316.

The Role of Patient Advocacy Groups

Patient advocacy groups can play a significant role in shaping market demand and pricing for drugs, especially those treating rare diseases:

1. Raising awareness about specific conditions
2. Lobbying for increased research funding
3. Advocating for favorable reimbursement policies

The influence of these groups should be factored into market analysis and price projections.

Data Analytics and Price Projections

Advanced data analytics techniques are increasingly being used to project drug prices and market trends:

1. Machine learning algorithms analyzing historical pricing data
2. Predictive modeling incorporating multiple market variables
3. Real-time data processing for dynamic pricing strategies

These tools can provide more accurate and nuanced projections for drugs like NDC 69452-0316.

Key Takeaways

• NDC 69452-0316 represents a specific drug product in the U.S. market.
• The orphan drug market has shown significant growth but may be experiencing a slowdown.
• Pricing mechanisms like AMP, URA, and MAC lists play crucial roles in determining drug prices.
• Market trends, legislative changes, and competitive landscapes significantly impact drug pricing and demand.
• Global market considerations and technological advancements can influence pricing strategies.
• Advanced data analytics are increasingly important for accurate price projections.

FAQs

1. What does the NDC 69452-0316 represent? NDC 69452-0316 is a unique identifier for a specific drug product in the United States, with 69452 representing the labeler (manufacturer or distributor), 031 indicating the product specifics, and 6 denoting the package type.

2. How do orphan drug market trends relate to NDC 69452-0316? While we don't have specific information about NDC 69452-0316, orphan drug market trends can provide context for niche pharmaceutical products. The orphan drug market has shown significant growth but is experiencing a slowdown, which could impact similar specialized drugs.

3. What factors are considered when projecting future drug prices? Factors include historical pricing data, market trends, legislative changes, competitive landscape, global market considerations, technological advancements, and the influence of patient advocacy groups.

4. How does the 340B Drug Pricing Program affect drug pricing? The 340B program requires drug manufacturers to offer discounted prices on certain outpatient drugs to eligible hospitals and other covered entities, potentially impacting the pricing strategy for drugs like NDC 69452-0316 if they are included in the program.

5. What role do data analytics play in price projections for drugs like NDC 69452-0316? Advanced data analytics, including machine learning algorithms and predictive modeling, are increasingly used to analyze historical data, market variables, and real-time information to provide more accurate and nuanced price projections for pharmaceutical products.

Sources cited: [1] https://www.evaluate.com/thought-leadership/orphan-drug-report-2024/ [2] https://www.drugpatentwatch.com/p/drug-price/ndc/69452-0146 [3] https://en.wikipedia.org/wiki/National_drug_code [5] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory